Last reviewed · How we verify

NCT04728178

Comparison of Perioperative Standard Fluid Management and Goal-Directed Fluid Management

Completed NA Last updated 28 January 2021
What this trial tests

NA trial testing Crystalloid solution in Perioperative Fluid Management in 60 participants. Completed in 1 May 2019.

Timeline
1 October 2017
Primary endpoint
1 January 2019
1 May 2019

Quick facts

Lead sponsorIstanbul University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 October 2017
Primary completion1 January 2019
Estimated completion1 May 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 18 to 80, any sex, with Perioperative Fluid Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the goal-directed fluid therapy based on the data obtained from the hemodynamic monitoring system, which provides continuous CO, SV and SVV measurements through arterial pressure wave with standard fluid therapy in perioperative fluid management of patients undergoing head and neck surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of Stroke Volume Variation-based goal-directed Therapy Versus Standard Fluid Therapy in Patients Undergoing Head and Neck Surgery: A Randomized Controlled Study
    Turkut N, Altun D, Canbolat N, Uzuntürk C, et al · · 2022 · cited 2× · PMID 35965423 · DOI 10.4274/balkanmedj.galenos.2022.2022-1-88

Verify or expand the search:

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04728178.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing